The abstract notes that AQP4-seronegative NMOSD cases differ systematically from seropositive cases in presentation and disease course, but provides no mechanistic explanation. Understanding this could reveal distinct pathophysiological pathways within NMOSD. Gap type: unexplained_observation Source paper: Uncommon Non-MS Demyelinating Disorders of the Central Nervous System. (2025, Current neurology and neuroscience reports, PMID:40591029)
Landscape Summary: Why do AQP4-seronegative NMOSD cases show distinct clinical features like bilateral ON and monophasic course? is a 0.79 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Why do AQP4-seronegative NMOSD cases show distinct clinical features like bilateral ON and monophasic course? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: